HB 803 revises Florida’s acupuncture practice act in several ways. It updates statutory definitions to more fully describe acupuncture, eastern oriental medicine, and related terms, and it expands the definition of “prescriptive rights” to include the prescription, administration, and use of needles, devices, and certain sterile herbs, homeopathics, vitamins, minerals, lipids, sugars, carbohydrates, and amino acids, while expressly excluding controlled substances, vaccinations, antibiotics, corticosteroids, botulinum toxin, and other non-acupuncture medications. The bill also revises licensure standards for acupuncturists, including education, examination, and fee provisions, and adds an express allowance for out-of-state acupuncturists to perform procedures or demonstrate equipment at board-approved continuing education programs.
The bill also makes conforming and technical changes to the acupuncture chapter, including continuing education rules, infection-control requirements, and prohibited-title provisions. It maintains the requirement that acupuncture needles be sterile and disposable and used only once, and it preserves restrictions on who may use acupuncture-related professional titles. The act is set to take effect July 1, 2025.
HB 803 would amend multiple sections of chapter 457, Florida Statutes, governing acupuncture licensure and practice. Its main legal effect is to broaden and clarify the scope of acupuncture and eastern oriental medicine practice, update licensure pathways and examination requirements, and align related provisions on continuing education, infection control, and professional title use. The bill would affect licensed acupuncturists, applicants for licensure, the Board of Acupuncture, the Department of Health, and educational providers approved by the board.
No committee transcripts or recorded votes were provided, so there is no direct evidence of debate, support, or opposition in the available materials. Based on the bill text alone, the measure appears to be a technical and scope-updating revision to an existing professional licensing framework rather than a highly controversial policy change. The fact that it later died in Senate Rules suggests it did not advance to final passage, but the available record does not show why.
The most likely areas of contention are the bill’s expansion and clarification of what acupuncturists may do under “prescriptive rights,” especially the inclusion of certain herbs, homeopathics, and nutritional supplements, and the exclusion of other drugs and controlled substances. Another possible point of concern is the licensure and educational standards, including the injection-therapy coursework and the recognition of out-of-state practitioners for educational demonstrations. Because no transcripts are available, specific stakeholder positions cannot be identified from the record.